Onemednet Corp (ONMD) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 available for investment. The lack of positive trading signals, weak financial performance, and absence of news or significant catalysts make it a less compelling opportunity currently. Holding off on this stock is advisable until stronger indicators emerge.

Technical Analysis

The MACD is positive and expanding, indicating a bullish momentum. However, the RSI is neutral, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5), suggesting a lack of strong upward trend. The pre-market price is above the pivot point (0.668) but below the next resistance level (R1: 0.725). Overall, the technical indicators are mixed and do not provide a strong buy signal.

Positive Catalysts

Revenue increased by 24.65% YoY in Q3 2025, indicating some growth in the business.

Neutral/Negative Catalysts

Net income dropped by -63.99% YoY, EPS declined by -85.71% YoY, and gross margin remains negative despite improvement. No significant news, hedge fund, or insider trading trends. No recent congress trading data available.

Financial Performance

In Q3 2025, revenue increased by 24.65% YoY to $177,000. However, net income dropped significantly to -$741,000 (-63.99% YoY), and EPS fell to -0.01 (-85.71% YoY). Gross margin improved but remains negative at -125.42%. Overall, the financial performance is weak with significant losses.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No data available for analyst ratings or price target changes.

Analyst Rating

Wall Street analysts forecast ONMD stock price to rise

Buy

Hold

Sell

Current: 1.020

Low

Averages

High